What specific health complications were observed in COVID-19 vaccine trials that were not adequately communicated to the public? - FinalLayer

According to vaccine trial participant Brianne Dressen, neurological complications were the primary health issues observed during COVID-19 vaccine trials. The data also revealed that vaccines did not prevent Long Covid as expected, and in many cases, actually made existing Long Covid symptoms worse rather than providing improvement. Most concerning was the apparent disconnect between what researchers and officials knew internally versus what was communicated publicly. Trial participants and the broader public were not fully informed about these complications, despite clear evidence of neurological side effects and the vaccines' limited effectiveness against Long Covid. This highlights critical issues around informed consent and transparency in vaccine safety reporting, particularly regarding the gap between private knowledge and public health messaging during the pandemic.